(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 19081.70 | 24950.30 | -23.52 | 76253.00 | 88798.20 | -14.13 | 76253.00 | 88798.20 | -14.13 |
| Other Income | 661.50 | 505.10 | 30.96 | 3490.10 | 1112.60 | 213.69 | 3490.10 | 1112.60 | 213.69 |
| PBIDT | 5548.50 | 11464.80 | -51.60 | 26966.90 | 39877.20 | -32.38 | 26966.90 | 39877.20 | -32.38 |
| Interest | 1.80 | 0.40 | 350.00 | 5.20 | 6.50 | -20.00 | 5.20 | 6.50 | -20.00 |
| PBDT | 5546.70 | 11464.40 | -51.62 | 26961.70 | 39870.70 | -32.38 | 26961.70 | 39870.70 | -32.38 |
| Depreciation | 866.30 | 807.50 | 7.28 | 3420.70 | 3105.50 | 10.15 | 3420.70 | 3105.50 | 10.15 |
| PBT | 4680.40 | 10656.90 | -56.08 | 23541.00 | 36765.20 | -35.97 | 23541.00 | 36765.20 | -35.97 |
| TAX | 1492.50 | 1827.30 | -18.32 | 5459.50 | 7279.80 | -25.00 | 5459.50 | 7279.80 | -25.00 |
| Deferred Tax | 437.40 | 380.40 | 14.98 | 1083.70 | 907.80 | 19.38 | 1083.70 | 907.80 | 19.38 |
| PAT | 3187.90 | 8829.60 | -63.90 | 18081.50 | 29485.40 | -38.68 | 18081.50 | 29485.40 | -38.68 |
| Equity | 530.90 | 530.90 | 0.00 | 530.90 | 530.90 | 0.00 | 530.90 | 530.90 | 0.00 |
| PBIDTM(%) | 29.08 | 45.95 | -36.72 | 35.37 | 44.91 | -21.25 | 35.37 | 44.91 | -21.25 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: